Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108


Photoaffinity antigens for human gammadelta T cells.

Sarikonda G, Wang H, Puan KJ, Liu XH, Lee HK, Song Y, Distefano MD, Oldfield E, Prestwich GD, Morita CT.

J Immunol. 2008 Dec 1;181(11):7738-50.


Butyrophilin 3A1 plays an essential role in prenyl pyrophosphate stimulation of human Vγ2Vδ2 T cells.

Wang H, Henry O, Distefano MD, Wang YC, Räikkönen J, Mönkkönen J, Tanaka Y, Morita CT.

J Immunol. 2013 Aug 1;191(3):1029-42. doi: 10.4049/jimmunol.1300658.


Conservation of nonpeptide antigen recognition by rhesus monkey V gamma 2V delta 2 T cells.

Wang H, Lee HK, Bukowski JF, Li H, Mariuzza RA, Chen ZW, Nam KH, Morita CT.

J Immunol. 2003 Apr 1;170(7):3696-706.


Definition of APC presentation of phosphoantigen (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate to Vgamma2Vdelta 2 TCR.

Wei H, Huang D, Lai X, Chen M, Zhong W, Wang R, Chen ZW.

J Immunol. 2008 Oct 1;181(7):4798-806.


Vgamma2Vdelta2 T Cell Receptor recognition of prenyl pyrophosphates is dependent on all CDRs.

Wang H, Fang Z, Morita CT.

J Immunol. 2010 Jun 1;184(11):6209-22. doi: 10.4049/jimmunol.1000231.


Structural features of nonpeptide prenyl pyrophosphates that determine their antigenicity for human gamma delta T cells.

Morita CT, Lee HK, Wang H, Li H, Mariuzza RA, Tanaka Y.

J Immunol. 2001 Jul 1;167(1):36-41.


Primary MHC-class II(+) cells are necessary to promote resting Vδ2 cell expansion in response to (E)-4-hydroxy-3-methyl-but-2-enyl-pyrophosphate and isopentenyl pyrophosphate.

Soriano-Sarabia N, Sandvold H, Jomaa H, Kubin T, Bein G, Hackstein H.

J Immunol. 2012 Dec 1;189(11):5212-22. doi: 10.4049/jimmunol.1200093.


Sensor Function for Butyrophilin 3A1 in Prenyl Pyrophosphate Stimulation of Human Vγ2Vδ2 T Cells.

Wang H, Morita CT.

J Immunol. 2015 Nov 15;195(10):4583-94. doi: 10.4049/jimmunol.1500314.


Preferential recognition of a microbial metabolite by human Vgamma2Vdelta2 T cells.

Puan KJ, Jin C, Wang H, Sarikonda G, Raker AM, Lee HK, Samuelson MI, Märker-Hermann E, Pasa-Tolic L, Nieves E, Giner JL, Kuzuyama T, Morita CT.

Int Immunol. 2007 May;19(5):657-73.


Activation of human γδ T cells by cytosolic interactions of BTN3A1 with soluble phosphoantigens and the cytoskeletal adaptor periplakin.

Rhodes DA, Chen HC, Price AJ, Keeble AH, Davey MS, James LC, Eberl M, Trowsdale J.

J Immunol. 2015 Mar 1;194(5):2390-8. doi: 10.4049/jimmunol.1401064.


Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gamma delta T cells.

Morita CT, Beckman EM, Bukowski JF, Tanaka Y, Band H, Bloom BR, Golan DE, Brenner MB.

Immunity. 1995 Oct;3(4):495-507.


Metabolic engineering of Salmonella vaccine bacteria to boost human Vγ2Vδ2 T cell immunity.

Workalemahu G, Wang H, Puan KJ, Nada MH, Kuzuyama T, Jones BD, Jin C, Morita CT.

J Immunol. 2014 Jul 15;193(2):708-21. doi: 10.4049/jimmunol.1302746.


Recognition of nonpeptide prenyl pyrophosphate antigens by human gammadelta T cells.

Morita CT, Lee HK, Leslie DS, Tanaka Y, Bukowski JF, Märker-Hermann E.

Microbes Infect. 1999 Mar;1(3):175-86. Review. No abstract available.


Indirect stimulation of human Vγ2Vδ2 T cells through alterations in isoprenoid metabolism.

Wang H, Sarikonda G, Puan KJ, Tanaka Y, Feng J, Giner JL, Cao R, Mönkkönen J, Oldfield E, Morita CT.

J Immunol. 2011 Nov 15;187(10):5099-113. doi: 10.4049/jimmunol.1002697.


Multifunctional immune responses of HMBPP-specific Vγ2Vδ2 T cells in M. tuberculosis and other infections.

Chen ZW.

Cell Mol Immunol. 2013 Jan;10(1):58-64. doi: 10.1038/cmi.2012.46. Review.


Gammadelta T cell immune manipulation during chronic phase of simian-human immunodeficiency virus infection [corrected] confers immunological benefits.

Ali Z, Yan L, Plagman N, Reichenberg A, Hintz M, Jomaa H, Villinger F, Chen ZW.

J Immunol. 2009 Oct 15;183(8):5407-17. doi: 10.4049/jimmunol.0901760. Erratum in: J Immunol. 2010 Jan 1;184(1):512.


Antitumor activity and some immunological properties of gammadelta T-cells from patients with gastrointestinal carcinomas.

Murayama M, Tanaka Y, Yagi J, Uchiyama T, Ogawa K.

Anticancer Res. 2008 Sep-Oct;28(5B):2921-31.

Supplemental Content

Support Center